Clinical Trials Logo

Uveitis, Intermediate clinical trials

View clinical trials related to Uveitis, Intermediate.

Filter by:

NCT ID: NCT01314469 Completed - Macular Edema Clinical Trials

Quality of Life in Patients With Intermediate Uveitis

Start date: n/a
Phase: N/A
Study type: Observational

The aim of this study is to determine if macular edema is associated with less visual function and quality of live in patients with intermediate uveitis

NCT ID: NCT01092533 Completed - Clinical trials for Uveitis, Intermediate

Myfortic for the Treatment of Non-infectious Intermediate Uveitis

MYCUV-IIT02
Start date: March 2010
Phase: Phase 3
Study type: Interventional

The objective of this clinical trial is to evaluate the efficacy, safety and tolerability of enteric-coated mycophenolate sodium (Myfortic®) in combination with low-dose corticosteroids (Decortin H®) compared to a monotherapy with low-dose corticosteroids (Decortin H®) in subjects with chronic intraocular inflammation (non-infectious intermediate uveitis).

NCT ID: NCT00908466 Completed - Uveitis Clinical Trials

Sirolimus as Therapeutic Approach to Uveitis

SAVE
Start date: July 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to find out about the safety and effectiveness of the study drug, sirolimus, in patients with uveitis and to utilize the potential effectiveness of sirolimus, and yet to avoid the potential complications of systemic use of the drug. In this study, the investigators will administer sirolimus either around (subconjunctival injection) or inside the eye (intravitreal injection). Local administration of sirolimus to the eye is not expected to have effects on the rest of the body. Therefore, it may offer a safer way than the current methods used to control the inflammation caused by non-infectious uveitis.

NCT ID: NCT00570830 Completed - Posterior Uveitis Clinical Trials

Retisert and Cataract Surgery in Patients With Severe Uveitis

Start date: September 2006
Phase: N/A
Study type: Interventional

To review chart data at the Duke Eye Center and determined whether a 3-year fluocinolone acetonide sustained drug delivery system (FA) safely suppressed postoperative inflammation when combined with phacoemulsification and posterior chamber intraocular lens implantation (phaco/PCIOL) in eyes with severe uveitis.

NCT ID: NCT00404742 Completed - Uveitis, Posterior Clinical Trials

A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

LUMINATE
Start date: January 2007
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and efficacy of LX211 as therapy in subjects with clinically quiescent non-infectious uveitis

NCT ID: NCT00404612 Completed - Uveitis, Posterior Clinical Trials

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

LUMINATE
Start date: January 2007
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and efficacy of LX211 as therapy in subjects with active non-infectious uveitis

NCT ID: NCT00344253 Completed - Multiple Sclerosis Clinical Trials

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate if interferon beta is superior to the standard treatment with Methotrexate for the treatment of intermediate uveitis and macular edema.

NCT ID: NCT00333814 Completed - Posterior Uveitis Clinical Trials

A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Start date: May 2006
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious intermediate or posterior uveitis.